MWPharmVet – Optimal dosage of drugs for veterinary medicine (Q9912)

From EU Knowledge Graph
Revision as of 07:47, 2 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in de: translated_label)
Jump to navigation Jump to search
Project Q9912 in Czech Republic
Language Label Description Also known as
English
MWPharmVet – Optimal dosage of drugs for veterinary medicine
Project Q9912 in Czech Republic

    Statements

    0 references
    0 references
    0 references
    3,600,000.0 Czech koruna
    0 references
    144,000.0 Euro
    10 January 2020
    0 references
    8,000,000.0 Czech koruna
    0 references
    320,000.0 Euro
    10 January 2020
    0 references
    45 percent
    0 references
    1 March 2017
    0 references
    9 October 2018
    0 references
    31 October 2018
    0 references
    MEDIWARE a.s.
    0 references

    50°5'39.41"N, 14°20'3.98"E
    0 references

    50°6'17.86"N, 14°22'51.35"E
    0 references
    16000
    0 references
    Firma MEDIWARE a.s. vyvinula a provozuje projekt MWPharm sloužící pro optimální návrh farmakoterapie pro humánní medicínu. V poslední době se zvyšuje poptávka (zejména ze zemí SAE) na obdobný projekt, který bude sloužit pro hospodářská zvířata, závodní koně, chovy velbloudů ale i malá zvířata (psy a kočky). Projekt MWPharVet bude tedy inovací projektu MWPharm zaměřený důsledně na veterinární medicínu a bude řešen v úzké spolupráci s fakultou veterinární a farmaceutickou v Brně. (Czech)
    0 references
    MEDIWARE a.s. has developed and operates the MWPharm project serving for optimal design of pharmacotherapy for human medicine. Recently, demand (especially from the UAE countries) has been increasing for a similar project that will serve for livestock, racing horses, camel breeding as well as small animals (dogs and cats). The MWPharVet project will therefore be an innovation of the MWPharm project focused on veterinary medicine and will be dealt with in close cooperation with the Faculty of Veterinary and Pharmaceutical Sciences in Brno. (English)
    22 October 2020
    0 references
    Mediware a.s. a développé et exploite le projet MWPharm pour une conception optimale de la pharmacothérapie pour la médecine humaine. Récemment, il y a eu une augmentation de la demande (en particulier des pays des Émirats arabes unis) pour un projet similaire qui servira le bétail, les chevaux de course, l’élevage de chameaux ainsi que les petits animaux (chiens et chats). Le projet MWPharVet sera donc une innovation du projet MWPharm axé de manière cohérente sur la médecine vétérinaire et sera traité en étroite collaboration avec la Faculté des sciences vétérinaires et pharmaceutiques de Brno. (French)
    28 November 2021
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/15_014/0001982
    0 references